Bruker Shares Rise Again on Upgrade | GenomeWeb

Shares in Bruker BioSciences rose more than 9 percent this past week following an upgrade by investment bank UBS on its stock from 'neutral' to 'buy.' The firm's shares gained 7.8 percent the previous week on news that it would acquire affiliated company Bruker Optics (see BioCommerce Week 4/19/2006). PerkinElmer and Stratagene led decliners for the tracking period, falling 3.72 percent and 3.21 percent, respectively.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.